http://archive.fast-edgar.com/20261002/A822S22CZ22EM2ZU222B2WE4MOBKGZ22Z282
Filed on: October 2, 2026
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 01, 2026
The Gorman-Rupp Company
(Exact name of Registrant as Specified in Its Charter)
... (continue reading...)
Terms supplement to the prospectus dated April 17, 2026, the prospectus supplement dated April 17, 2026, the product supplement no. 3-I dated April 17, 2026, the underlying supplement no. 5-I dated April 17, 2026 Registration Statement Nos. 333-293684 and 333-293684-01 Dated September 30, 2026 Rule 424(b)(3) North America Structured Investments 2.92yr MQUSTVA Buffered Equity Notes ... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13... (continue reading...)
Terms supplement to the prospectus dated April 17, 2026, the prospectus supplement dated April 17, 2026, the product supplement no. 3-I dated April 17, 2026, the underlying supplement no. 5-I dated April 17, 2026 Registration Statement Nos. 333-293684 and 333-293684-01 Dated September 30, 2026 Rule 424(b)(3) North America Structured Investments 5yr MQUSTVA Buffered Equity Notes J.P.... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC
-
Form 4 Nayax Ltd. For: Sep 30 Filed by: Nechmad Yair
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 4 Prenetics Global Ltd For: Sep 30 Filed by: Lo Hoi Chun
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 CDT Equity Inc.
-
Form 8-K ALPHA MODUS HOLDINGS, For: Oct 01
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 4 Pyxis Oncology, Inc. For: Oct 01 Filed by: Gordon Craig D
-
Form 6-K Kanzhun Ltd For: Oct 02
-
Form 8-K FREEPORT-MCMORAN INC For: Oct 02
-
Form 424B2 CITIGROUP INC
-
Form 424B3 JPMORGAN CHASE & CO
-
Form SCHEDULE 13G/A Pyxis Oncology, Inc. Filed by: GordonMD Global Investments LP
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 8-K SCIENTIFIC INDUSTRIES For: Oct 01
-
Form N-MFP3 PENN SERIES FUNDS INC For: Sep 30
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 4 Launch Two Acquisition For: Sep 30 Filed by: Gilbert Ryan Mark
-
Form 8-K Blue Owl Technology Inco For: Oct 02
-
Form 8-K Blue Owl Credit Income For: Oct 02
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form 6-K Dingdong (Cayman) Ltd For: Oct 02
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 8-K Rivian Automotive, Inc. For: Oct 02
-
Form 4 XPO, Inc. For: Oct 01 Filed by: Bates David J.
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 4 Agora, Inc. For: Oct 01 Filed by: He Eric
-
Form 424B2 CITIGROUP INC
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 497J Tidal Trust I
-
Form 4 XPO, Inc. For: Oct 01 Filed by: Wismans Kyle
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 20FR12B Kelly Partners Group
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 8-K INTEGRA LIFESCIENCES For: Oct 02

